Диссертация (1147802), страница 35
Текст из файла (страница 35)
Understanding patients’ adherence-related beliefs about medicinesprescribed for long-term conditions: a meta-analytic review of the NecessityConcerns Framework / R. Horne, S.C. Chapman, R. Parham et al. // PLОSOne [Electronic resource]. – 2013. – Vol.
8 (12). – URL: http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0080633–Dateofaccess: 10.10.2014.285. Insull W. The problem of compliance to cholesterol altering therapy /W. Insull // J. Intern. Med. – 1997. – Vol. 241 (4). – Р. 317-325.286. Jacobs A.K. Better outcome for women compared with men undergoingcoronaryrevascularization:areportfromthebypassangioplastyrevascularization investigation (BARI) / A.K. Jacobs, S.F. Kelsey,M.M. Brooks et al.
// Circulation. – 1998. – Vol. 98 (13). – P. 1279-1285.287. Jin J. Factors affecting therapeutic compliance: A review from the patient’sperspective / J. Jin, G.E. Sklar, V. Min Sen Oh, et al. // Therapeutics andClinical Risk Management – 2008. – Vol. 4 (1). – P. 269-286.288. Jindal R.M. Noncompliance after kidney transplantation: a systematicreview / R.M.
Jindal, J.T. Joseph, M.C. Morris et al. // Transplant Proc – 2003.– Vol. 35 (8). – P. 2868-2872.289. Joho A.A. Factors affecting treatment compliance among hypertensionpatients in three District Нospitals – Dar es Salaam: dissertation MSc Nursing(Critical Care & Trauma) Muhimbili University of Health and Allied Sciences/ A.A. Joho. – October, 2012.
– 68 p.290. Kaplan R.C. Race, ethnicity, and sociocultural characteristics predictnoncompliance with lipid – lowering medications / R.C. Kaplan,N.C. Bhalodkar, E.J. Brown et al. // Prev Med. – 2004. – Vol. 39 (6). –P. 1249-1255.291. Karamanidou C. A systematic review of the prevalence and determinants ofnonadherence to phosphate binding medication in patients with end-stage renaldisease / C. Karamanidou, J. Clatworthy, J. Weinman, et al. // BMC Nephrol201[Electronic resource].
– 2008. – Vol. 9. – URL: doi: 10.1186/1471-2369-9-2. –Date of access: 10.09.2014.292. Kardas P. Determinants of patient adherence: a review of systematic reviews/ P. Kardas, P. Lewek, M. Matyjaszczyk // Frontiers in Pharmacology[Electronic resource]. – 2013. – Vol. 4.
– URL: doi: 10.3389/fphar.2013.00091. – Date of access: 10.09.2014.293. Kaufmann M.W. Relation between myocardial infarction, depression,hostility, and death / M.W. Kaufmann, J.P. Fitzgibbons, E.J. Sussman // AmHeart J. – 1999. – Vol. 138 (3). – P. 549-554.294. Koszycki D. An open-label trial of interpersonal psychotherapy in depressedpatients with coronary disease / D. Koszycki, S.
Lafontaine, N. Frasure-Smithet al. // Psychosomatics. – 2004. – Vol. 45 (4). – P. 319-324.295. Krueger K. Age-related medication adherence in patients with chronic heartfailure: A systematic literature review / K. Krueger, L. Botermann, S.G. Schorret al. // International Journal of Cardiology [Electronic resource]. – 2015. –Vol. 184. – P. 728-735. – URL: doi: 10.1016/j.ijcard.2015.03.042.
– Date ofaccess: 10.09.2014.296. Kulik A. Adherence to statin therapy in elderly patients after hospitalizationfor coronary revascularization / A. Kulik, W.H. Shrank, R. Levin et al. // TheAmerican Journal of Cardiology. – 2011. – Vol. 107 (10). – P. 1409-1414.297. Laba T.-L. Understanding if, how and why non-adherent decisions are madein an Australian community sample: a key to sustaining medication adherencein chronic disease? / T.-L.
Laba, E. Lehnbom, J.A. Brien, et al. // Research inSocial and Administrative Pharmacy. – 2015. – Vol. 11 (2). – P. 154-162.298. Lazarus R.S. Psychological stress and the coping process / R.S. Lazarus. –New York: McGraw-Hill, 1966. – 466 p.299. Lehane E. Intentional and unintentional medication non-adherence: acomprehensive framework for clinical research and practice? A discussion202paper / E. Lehane, G.
McCarthy // International Journal of Nursing Studies. –2007. – Vol. 44 (8). – Р. 1468-1477.300. Leong J. Adherence to health recommendations after a cardiac rehabilitationprogramme in post-myocardial infarction patients: the role of health beliefs,locus of control and psychological status / J. Leong, A. Molassiotis, H. Marsh// Clinical Effectiveness in Nursing. – 2004. – Vol. 8. – P. 26-38.301. Lloyd-Jones D.M. Defining and setting national goals for cardiovascularhealth promotion and disease reduction: the American Heart Association’sstrategic Impact Goal through 2020 and beyond / D.M.
Lloyd-Jones, Y. Hong,D. Labarthe et al. // Circulation. – 2010. – Vol. 121 (4). – Р. 586-613.302. Löffler W. Schizophrenic patients’ subjective reasons for compliance andnoncompliance with neuroleptic treatment / W. Löffler, R. Kilian, M. Toumi etal. // Pharmacopsychiatry. – 2003. – Vol. 36 (3). – P. 105-112.303. Lowe L.P.
Impact of major cardiovascular risk factors, particularly incombination, on 22-year mortality in women and men / L.P. Lowe,Р. Greenland, K.J. Ruth et al. // Arch Intern Med – 1998. – Vol. 158 (18). –Р. 2007-2014.304. Lowry K.P. Intentional and unintentional nonadherence to antihypertensivemedication / K.P. Lowry, T.K. Dudley, E.Z. Oddone et al. // Annals ofPharmacotherapy. – 2005. – Vol. 39 (7-8). – Р.
1198-1203.305. Marchena-Giráldez C. La importancia de las instrucciones del psicólogopara favorecer la adhesión terapéutica / C. Marchena-Giráldez, A. CaleroElvira, N. Galván-Domínguez // Clínica y Salud. – 2013. – Vol. 24. – Р. 55-65.306. Martín Alfonso L.Á., Marco conceptual para la evaluación y mejora de laadherencia a los tratamientos médicos en enfermedades crónicas / L.Á. MartínAlfonso, J.A. Grau Ábalo, A.D. Espinosa Brito // Revista Cubana de SaludPública. – 2014.
– Vol. 40 (2). – P. 225-238.203307. Mason B.J. Assessment of sulfonylurea adherence and metabolic control /B.J. Mason, J.R. Matsuyama, S.G. Jue // Diabetes Educ. – 1995. – Vol. 21 (1).– Р. 52-57.308. Mathes T. Adherence influencing factors – a systematic review of systematicreviews / T. Mathes, T. Jaschinski, D. Pieper // Archives of Public Health[Electronic resource]. – 2014 – Vol. 72 (1). – URL: http://www.archpublichealth.com/content/72/1/37 (doi: 10.1186/2049-3258-72-37) – Date of access:10.09.2014.309.
Mayou R.A. Depression and anxiety as predictors of outcome aftermyocardia infarction / R.A. Mayou, D. Gill, D.R. Thompson // Psychosom.Med. – 2000. – Vol. 60. – Р. 627-636.310. McHorney C.A. The Adherence Estimator: a brief, proximal screener forpatient propensity to adhere to prescription medications for chronic disease /C.A. McHorney // Curr Med Res Opin. – 2009. – Vol.
25 (1). – Р. 215-238.311. Mills E.J. Adherence to HAART: a systematic review of developed anddeveloping nation patient-reported barriers and facilitators / E.J. Mills,J.B. Nachega, D.R. Bangsberg et al. // PLoS Medicine [Electronic resource]. –2006. – Vol. 3 (11). – URL: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0030438 – Date of access: 10.10.2014.312.
Miura T. Effect of digoxin noncompliance on hospitalization and mortalityin patients with heart failure in long-term therapy: a prospective cohort study /T. Miura, R. Kojima, M. Mizutani et al. // Eur J Clin Pharmacol – 2001. –Vol. 57 (1). – Р. 77-83.313. Molloy G.J. Intentional and unintentional non-adherence to medicationsfollowing an acute coronary syndrome: a longitudinal study / G.J.
Molloy,N. Messerli-Bürgy, G. Hutton et al. // Journal of Psychosomatic Research. –2014. – Vol. 76 (5). – Р. 430-432.314. Monane M. Compliance with antihypertensive therapy among elderyMedical enrollees: the role of age, gender, and race / M. Monane, R.L. Bohn,204J.H. Gurwitz et al. // Am J Public Health. – 1996. – Vol. 86 (12). – Р. 18051808.315.
Morisky D.E. Predictive validity of a medication adherence measure in anoutpatient setting / D.E. Morisky, A. Ang, M. Krousel-Wood, et al. // J. Clin.Hypertens (Greenwich). – 2008. – Vol. 10 (5). – Р. 348-354.316. Morisky D.E. Concurrent and predictive validity of a self-reported measureof medication adherence / D.E. Morisky, L.W. Green, D.M. Levine // Med.Care. – 1986. – Vol. 24 (1). – Р. 67-74.317. Munro S.A. Patient adherence to tuberculosis treatment: a systematic reviewof qualitative research / S.A. Munro, S.A.
Lewin, H.J. Smith et al. // PLoSMedicine [Electronic resource]. – 2007. – Vol. 4 (7). – e238. – URL:http://www.ncbi.nlm.nih.gov/pubmed/17676945 – Date of access: 10.09.2014.318. Murray C.J. Global mortality, disability, and contribution of risk factors:Global Burden of Disease Study / C.J. Murray, A.D. Lopez // Lancet. – 1997.– Vol. 349 (9063). – Р. 1436-1442.319. Nemeroff C.B. Evolutionary trends in the pharmacoterapeutic managementof depression / C.B.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
